Richard Burr: “What I have found is this issue is just as confusing as it was 22 years ago when I started on it.”

Nobody has worked harder on this issue, I think, on the Hill than I have.

The FDA failed to do its job, plain and simple.

The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.

Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.